Kristin Maloney

Ms. Kristin Maloney

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2023 in Nature Medicine
Verified
Journal Article
Open access
PDF file
DTDeirdre K. Tobias
Deirdre K. Tobias
JMJordi Merino
Jordi Merino
AAAbrar Ahmad
Abrar Ahmad
CACatherine Aiken
Catherine Aiken
JBJamie L. Benham
Jamie L. Benham
PFPaul W Franks
Paul W Franks
Precision medicine is part of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and optimize outcomes when making medical decisions and health recommendations. Diabetes affects hundreds of millions of people worldwide, many of whom will develop life-threatening complications and die prematurely. Precision medicine can potentially address this enormous problem by accounting for heterogeneity in the etiology, clinical presentation and pathogenesis of common forms of diabetes and risks of complications. This second international consensus report on precision diabetes medicine summarizes the findings from a systematic evidence review across the key pillars of precision medicine (prevention, diagnosis, treatment, prognosis) in four recognized forms of diabetes (monogenic, gestational, type 1, type 2). These reviews address key questions about the translation of precision medicine research into practice. Although not complete, owing to the vast literature on this topic, they revealed opportunities for the immediate or near-term clinical implementation of precision diabetes medicine; furthermore, we expose important gaps in knowledge, focusing on the need to obtain new clinically relevant evidence. Gaps include the need for common standards for clinical readiness, including consideration of cost-effectiveness, health equity, predictive accuracy, liability and accessibility. Key milestones are outlined for the broad clinical implementation of precision diabetes medicine.

26 December 2017 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
PEPhilip Empey
Philip Empey
JSJames M. Stevenson
James M. Stevenson
STSony Tuteja
Sony Tuteja
KWKristin W. Weitzel
Kristin W. Weitzel
DADominick J. Angiolillo
Dominick J. Angiolillo
ONOn Behalf Of The Ignite Network
On Behalf Of The Ignite Network

17 March 2016 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
JKJeffrey Kleinberger
Jeffrey Kleinberger
KMKristin Maloney
Kristin Maloney
TPToni I. Pollin
Toni I. Pollin
LJLinda Jo Bone Jeng
Linda Jo Bone Jeng

9 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JGJulia K. Goodrich
Julia K. Goodrich
MSMoriel Singer-Berk
Moriel Singer-Berk
RSRachel Son
Rachel Son
ASAbigail Sveden
Abigail Sveden
JWJordan Wood
Jordan Wood
MUMiriam S. Udler
Miriam S. Udler
Hundreds of thousands of genetic variants have been reported to cause severe monogenic diseases, but the probability that a variant carrier develops the disease (termed penetrance) is unknown for virtually all of them. Additionally, the clinical utility of common polygenetic variation remains uncertain. Using exome sequencing from 77,184 adult individuals (38,618 multi-ancestral individuals from a type 2 diabetes case-control study and 38,566 participants from the UK Biobank, for whom genotype array data were also available), we apply clinical standard-of-care gene variant curation for eight monogenic metabolic conditions. Rare variants causing monogenic diabetes and dyslipidemias display effect sizes significantly larger than the top 1% of the corresponding polygenic scores. Nevertheless, penetrance estimates for monogenic variant carriers average 60% or lower for most conditions. We assess epidemiologic and genetic factors contributing to risk prediction in monogenic variant carriers, demonstrating that inclusion of polygenic variation significantly improves biomarker estimation for two monogenic dyslipidemias.

10 March 2014 in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Verified
Journal Article
Closed access
PDF file
ASAlan R. Shuldiner
Alan R. Shuldiner
KPKathleen Palmer
Kathleen Palmer
RPRuth E. Pakyz
Ruth E. Pakyz
TATameka D. Alestock
Tameka D. Alestock
KMKristin Maloney
Kristin Maloney
MVMark R. Vesely
Mark R. Vesely

30 July 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KMKristin Maloney
Kristin Maloney
LSLori L. Sullivan
Lori L. Sullivan
JMJustyne E. Matheny
Justyne E. Matheny
ESErin D. Strome
Erin D. Strome
SMStephanie L. Merrett
Stephanie L. Merrett
BSBeth Sullivan
Beth Sullivan
Human centromeres are defined by megabases of homogenous alpha-satellite DNA arrays that are packaged into specialized chromatin marked by the centromeric histone variant, centromeric protein A (CENP-A). Although most human chromosomes have a single higher-order repeat (HOR) array of alpha satellites, several chromosomes have more than one HOR array. Homo sapiens chromosome 17 (HSA17) has two juxtaposed HOR arrays, D17Z1 and D17Z1-B. Only D17Z1 has been linked to CENP-A chromatin assembly. Here, we use human artificial chromosome assembly assays to show that both D17Z1 and D17Z1-B can support de novo centromere assembly independently. We extend these in vitro studies and demonstrate, using immunostaining and chromatin analyses, that in human cells the centromere can be assembled at D17Z1 or D17Z1-B. Intriguingly, some humans are functional heterozygotes, meaning that CENP-A is located at a different HOR array on the two HSA17 homologs. The site of CENP-A assembly on HSA17 is stable and is transmitted through meiosis, as evidenced by inheritance of CENP-A location through multigenerational families. Differences in histone modifications are not linked clearly with active and inactive D17Z1 and D17Z1-B arrays; however, we detect a correlation between the presence of variant repeat units of D17Z1 and CENP-A assembly at the opposite array, D17Z1-B. Our studies reveal the presence of centromeric epialleles on an endogenous human chromosome and suggest genomic complexities underlying the mechanisms that determine centromere identity in humans.